Abstract
Aim
Changes in the prevalence of hepatitis C virus (HCV) genotypes could have considerable impacts on prognosis and therapy of hepatitis C. We aimed to investigate the current distribution of HCV genotypes in Henan province, China, and to assess factors associated with the sort of genotype and evolution of the distribution pattern of HCV genotypes.
Subject and methods
A total of 362 chronic hepatitis C (CHC) patients were enrolled retrospectively in the study. HCV genotypes were determined by DNA sequencing and phylogenetic analysis of the core and/or NS5B regions. Univariate or multivariate analysis was performed for factors associated with HCV genotypes distribution.
Results
Among the 362 samples, the most prevalent genotype was 1b (58.6%), followed by 2a (15.7%), 6a (13.8%), 3a (7.5%), 3b (2.8%), 1a (0.8%), and 2b (0.8%). Multivariate logistic regression models showed that transmission routes and age were independently associated with HCV genotypes. Transfusion of blood or blood product was independently associated with genotype 1b (OR:2.22; 95%CI 1.22–4.04, P = 0.009), while IDU was independently associated with genotype 6a (OR:3.18; 95%CI 1.34–7.51, P = 0.009). Genotype 1b was more frequent in older age patients (OR:1.02; 95%CI 1.00–1.04, P = 0.023), and genotype 6a was more common in younger age individuals (OR:0.97; 95%CI 0.94–0.99, P = 0.029). Changes in HCV genotype distribution were present depending on the year of infection. The prevalence of the HCV genotype 1b decreased over time, while the prevalence of the HCV genotype 6a increased over time.
Conclusions
The most prevalent genotype was still 1b among CHC patients in the Henan province, China. The prevalence of genotype 1b has decreased overtime, and that of genotype 6a has increased in younger patients. The change is attributed to a shift in HCV transmission routes. This study provided further evidence for the prevention and treatment of hepatitis C in future.
Similar content being viewed by others
Change history
30 January 2018
The journal had been advised to revise the title so that Clarivate Analytics can try to count the citations more accurately. There’s been confusion due to the existence of another journal with the same name.
Abbreviations
- HCV:
-
Hepatitis C Virus
- CHC:
-
Chronic hepatitis C
- IDU:
-
Intravenous drug use
- AST:
-
Aspartate aminotransferse
- ALT:
-
Alanine aminotransferse
- IQR:
-
Inter Quartile Range
- ANOVA:
-
Analysis of Variance
References
Bao YP, Liu ZM, Lu L (2010) Review of HIV and HCV infection among drug users in China. Curr Opin Psychiatry 23(3):187–194
Bourliere M, Bourlière M, Barberin JM, Rotily M, Guagliardo V, Portal I, Lecomte L, Benali S, Boustière C, Perrier H, Jullien M, Lambot G, Loyer R, LeBars O, Daniel R, Khiri H, Halfon P (2002) Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. J Viral Hepat 9(1):62–70
Chu TX, Levy JA (2005) Injection drug use and HIV/AIDS transmission in China. Cell Res 15(11–12):865–869
Cui WG, Xue XJ, Liu CH, Sun GQ, Liu J, Fan PY, Tian SA, Sun DY, Xing WG, Wang Z (2013) Epidemiological survey on the hepatitis C virus and its genotyping analysis in Henan province in 2012 (in Chinese). Zhong hua Yu Fang Yi Xue Za Zhi 47(6):518–522
Esteban JI, Sauleda S, Quer J (2008) The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 48(1):148–162
Fu Y, Qin W, Cao H, Xu R, Tan Y, Lu T, Wang H, Tong W, Rong X, Li G, Yuan M, Li C, Abe K, Lu L, Chen G (2012) HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS One 7(1):e28006
Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K (2011) New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat 18(1):42–52
Gao X, Cui Q, Shi X, Su J, Peng Z, Chen X, Lei N, Ding K, Wang L, Yu R, Wang N (2011) Prevalence and trend of hepatitis C virus infection among blood donors in Chinese mainland: a systematic review and meta-analysis. BMC Infect Dis 11:88
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H (2014) Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 61(1 Suppl):S45–S57
Liu X, Wang DS, Zhang SM, Xiong SS, Ji ZD, Qi ZB, Wang YC, Mai K (2000) Determination of hepatic C virus genotypes in Henan province (in Chinese). World Chin J Digestol 8(8):922–923
Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH (2005) Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol 75(4):538–549
Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E (2015) Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 61(1):77–87
Pawlotsky JM, Tsakiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D (1995) Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171(6):1607–1610
Rao H, Wei L, Lopez-Talavera JC, Shang J, Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, Jiang J, Sun Y, Yang R, Li H, Zhang H, Gong Z, Zhang L, Zhao L, Dou X, Niu J, You H, Chen Z, Ning Q, Gong G, Wu S, Ji W, Mao Q, Tang H, Li S, Wei S, Sun J, Jiang J, Lu L, Jia J, Zhuang H (2014) Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 29(3):545–553
Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL (2000) Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 182(3):698–707
Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P (2014) Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 59(1):318–327
Tian D, Li L, Liu Y, Li H, Xu X, Li J (2012) Different HCV genotype distributions of HIV-infected individuals in Henan and Guangxi, China. PLoS One 7(11):e50343
Xu QT, Du SC, Tao QM, Li XM, Xiong FS (2003) Significance of comparing hepatic C virus genome with restriction endonuclease between 5′-NCR and NS5B region (in Chinese). Chin J Clin Hepatol 19(1):20–21
Zhou Y, Wang X, Mao Q, Fan Y, Zhu Y, Zhang X, Lan L, Jiang L, Tan W (2009) Changes in modes of hepatitis C infection acquisition and genotypes in Southwest China. J Clin Virol 46(3):230–233
Acknowledgments
We thank the patients for providing serum samples.
Funding
This work was supported by the Science Research Project of the Henan Province (No. 162102310030; No. 162300410294; No. 152102310135; No. 201401015) and the grants from China National Key Clinical Specialty Discipline Construction Program (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was performed in accordance with the ethical standards of the Declaration of Helsinki. Guidelines set by the Institution Review Board of Zhengzhou University People’s Hospital, were strictly followed. Written informed consent was obtained from all patients. All authors have read and approved this version of the article. No conflict of interest exits in the submission of this manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
The original version of this article was revised: Due to the existence of another journal with the same name, the Publisher has added a subtitle, “From Theory to Practice.” Effective as of January 2018, the new title of this Journal is Journal of Public Health: From Theory to Practice.
A correction to this article is available online at https://doi.org/10.1007/s10389-017-0893-1.
Rights and permissions
About this article
Cite this article
Li, W., Xi, L., Cai, Q. et al. Changes in the distribution of hepatitis C virus genotypes and their association with shifts in transmission routes in Henan, China. J Public Health 26, 157–162 (2018). https://doi.org/10.1007/s10389-017-0845-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10389-017-0845-9